Interleukin-33 drives hepatic fibrosis through activation of hepatic stellate cells.
about
Chronic Alcohol Consumption Promotes Diethylnitrosamine-Induced Hepatocarcinogenesis via Immune Disturbances.Interleukin-33 in the pathogenesis of liver fibrosis: alarming ILC2 and hepatic stellate cells.IL-33-ST2 Axis in Liver Disease: Progression and Challenge.The effects of IL-33 on airways collagen deposition and matrix metalloproteinase expression in a murine surrogate of asthma.Adiponectin and the steatosis marker Chi3L1 decrease following switch to raltegravir compared to continued PI/NNRTI-based antiretroviral therapy.IL-33/ST2 Axis in Organ Fibrosis
P2860
Interleukin-33 drives hepatic fibrosis through activation of hepatic stellate cells.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Interleukin-33 drives hepatic fibrosis through activation of hepatic stellate cells.
@en
Interleukin-33 drives hepatic fibrosis through activation of hepatic stellate cells.
@nl
type
label
Interleukin-33 drives hepatic fibrosis through activation of hepatic stellate cells.
@en
Interleukin-33 drives hepatic fibrosis through activation of hepatic stellate cells.
@nl
prefLabel
Interleukin-33 drives hepatic fibrosis through activation of hepatic stellate cells.
@en
Interleukin-33 drives hepatic fibrosis through activation of hepatic stellate cells.
@nl
P2093
P2860
P356
P1476
Interleukin-33 drives hepatic fibrosis through activation of hepatic stellate cells.
@en
P2093
Beicheng Sun
Isabelle Maillet
Junwei Tang
Qianghui Liu
Runqiu Jiang
Siamak S Shoto
Valerie Quesniaux
Wenjie Zhang
Zhongming Tan
P2860
P2888
P356
10.1038/CMI.2016.63
P577
2017-02-13T00:00:00Z